Pre Clinical & Clinical Services – GLP & GCP Compliant

Bioanalysis of small molecules & generics

LC-MS/MS API 6500

BIOEQUIVALENCE STUDIES

Bioequivalence - clinical studies

BIOANALYSIS & IMMUNOGENICITY OF BIOLOGICS & BIOSIMILARS

Meso QuickPlex SQ

BIOANALYSIS OF NUCLEIC ACIDS

Oligo testing

BIOMARKER ANALYSIS

cell-based and potency assays

PK EVALUATION AND STATISTICS

PKPD evaliation

PERCUTANEOUS ABSORPTION

Percutaneous Absorption

Enzyme activities

Bioanalysis quantification

HISTOPATHOLOGY

Histopathology

Testimonials

Celltrion logo

“We are currently developing multiple new biosimilar projects and consider Kymos one of the best CROs in Europe for drug release and testing.”

Yong Suk Yang, Global QC Operation Team Manager, CELLTRION, INC
Combino_Logo

“We were positively impressed when Kymos reacted to our needs by investing in their stability capabilities, and now, two years down the line, with projects in full-swing, I can safely say that we made the right choice. In Kymos we have found a reliable, committed, trustworthy and professional partner.”

Dr. Dino Mangion, Head of Malta Operations, MEDICHEM/COMBINO PHARMA Ltd
Helm Logo

“Back in 2017 there weren’t many analytical CROs able to carry out Franz cell assays and Kymos’ pioneering work was pivotal for the registration of our product.”

Dr. Marius Strunk, Senior Pharmaceutical Development Manager, HELM AG
PharmaMar Logo

“Kymos offered superior historical expertise by being exposed to so many different clients, pharmacological compounds, and therapeutic areas. They addressed and anticipated very diverse problems.”

Dr. Pablo Avilés, PHARMAMAR S.A.
Exeltis_Logo

“I have had a long and fruitful experience with Kymos and have a huge interest in their participation owing to their reliability.”

Jaime Algorta, Medical Affairs Director , EXELTIS HEALTHCARE S.L.U.
Omeicos_Logo

“Prolytic is our analytical partner throughout the entire drug development process. Such a long and complex process requires a laboratory you can trust. Professional yet flexible, Prolytic accompanies us through the preclinical and clinical phases.”

TEchnical university Darmstadt_Logo

“Establishing robust miRNA methods for valuable results is tricky. The team at Prolytic have been a key collaboration partner. With their 30 years of experience in bioanalytics and broad know-how in different techniques, study types, and substance groups, we were able to quickly develop a reproducible and reliable analysis method for miRNAs.”

Dr. Meike Saul, Research Group Leader, Technische Universität Darmstadt

Get in touch

  • KOREA PHARM & BIO: Goyang, KR | 23-26 Apr 2024

  • BIO KOREA 2024: Seoul, KR | 08-10 May 2024

  • BIO International Convention: San Diego, US | 3-6 Jun 2024

  • Congrès POLEPHARMA Biotesting: Évreux, FR | 5-6 Jun 2024

  • AFI Symposium: Rimini, IT | 5-7 Jun 2024

  • BIOPLUS – INTERPHEX KOREA: Seoul, KR | 10-12 Jul 2024

  • Farmaforum: Madrid, ES | 25-26 Sep 2024

  • Biomarkers Europe 2024: Basel, CH | 30 Sep – 01 Oct 2024

  • CPHI 2024: Milan, IT | 8-10 Oct 2024

  • BIO-Europe Autumn: Stockholm, SE | 4-6 Nov 2024

  • European Bioanalysis Forum: Barcelona, ES | 20-22 Nov 2024

  • PharmaLab Congress: Düsseldorf, DE | 25-27 Nov 2024

  • I4ID 2024: Lyon, FR | 27-28 Nov 2024

    map with kymos group locations

    Laboratories

    logo of Kymos

    Barcelona
    Spain

    logo of Prolytic

    Frankfurt
    Germany

    logo of Pharmaprogress

    Ancona
    Italy

    Offices

    icon ofice samall

    Paris
    France

    icon ofice samall

    Milano
    Italy

    Branches

    logo of Kymos for KR branch

    Seoul
    Korea